Looking to publish in Journal of Crohn s and Colitis? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginJournal of Crohn’s and Colitis is a gastroenterology journal published by Oxford University Press for the European Crohn's and Colitis Organisation (ECCO). It publishes research on Crohn’s disease, ulcerative colitis, inflammatory bowel disease, guidelines, consensus papers, reviews, and related content. The journal has a 2024 Impact Factor of 8.7 and a 2024 CiteScore of 15.6. Online ISSN: 1876-4479.
Looking to publish in Journal of Crohn s and Colitis? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Journal of Crohn s and Colitis accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review Article
Viewpoint
Short Report
Letter To The Editor
Editorial
Recent Publications
Noninfectious skin lesions in Crohn’s disease patients treated with ustekinumab: a multicenter observational retrospective GETAID study
Gauthier Piga, Aurélien Amiot, Joelle Bonnet, Axel P Villani, Gilles Boschetti, Claire Gay, Anne-Laure Charlois, Alban Benezech, Xavier Hébuterne, David Laharie, Laurent Peyrin-Biroulet, Stéphane Nancey
Dual therapy with tofacitinib and steroids for acute severe ulcerative colitis: a randomized double-blind placebo-controlled trial
Umang Arora, Mahak Verma, Divya Madan, Mukesh Singh, Devasenathipathy Kandasamy, Himanshu Narang, Manjeet Goyal, Mridul Mahajan, Sandeep K Mundhra, Shubham Prasad, Malambo Mubunnu, Ankur Goyal, Rajesh Panwar, Tushar Sehgal, Nihar Ranjan Dash, Raju Sharma, Vaishali Bhardwaj, Saurabh Kedia, Govind Makharia, Vineet Ahuja
Review: optimizing rescue therapy in acute severe ulcerative colitis using infliximab pharmacokinetics—a practical guide for clinicians
Danny Con, Christopher Li Wai Suen, Matthew Choy, Jennifer A Flegg, Peter De Cruz
From mechanical stress to mesenteric adipocyte dysfunction in Crohn’s disease: an essential role of Piezo1-mediated mitochondrial calcium overload
Lugen Zuo, Lian Wang, Qingqing Huang, Jingjing Yang, Xiaohua Chen, Bowen Song, Hui Lu, Sitang Ge, Jing Li, Xue Song, Yueyue Wang, Zhijun Geng, Jianguo Hu
Perianal fistulizing Crohn’s disease increases infliximab clearance and causes low infliximab exposure (ATLANTIC)
Lieven G M Mulders, Suzanne I Anjie, Manon Chevallot-Beroux, Floris Loeff, Manon E Wildenberg, Ron A A Mathôt, Geert R A M D’Haens, Krisztina B Gecse
Frequently asked questions
How long does it take to publish?
2025 median days from acceptance to publication: 21 days.
Reformat to Journal of Crohn s and Colitis using Livewrite PremiumIs a cover letter required?
A covering letter is expected when explaining the case for joint or equal first authorship.
Reformat to Journal of Crohn s and Colitis using Livewrite PremiumWhat are the publication costs?
Subscription journal with open access publishing options available, including publication through institutional Read and Publish agreements.
Reformat to Journal of Crohn s and Colitis using Livewrite Premium